Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?;Rezidiv der grunderkrankung nach lebertransplantation. Ein therapeutisches dilemma oder therapierbar?

Medizinische Klinik

Volumn 101, Issue 12, 2006, Pages 939-950

  Beckebaum, Susanne ^a   Cicinnati, Vito R ^a   Broelsch, Christoph E ^a   Gerken, Guido ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Liver transplantation; Prevention; Recurrrent disease; Treatment

Indexed keywords

ALPHA INTERFERON; HYPERIMMUNE GLOBULIN; NUCLEOSIDE ANALOG; RIBAVIRIN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; GENOTYPE; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; PATIENT COMPLIANCE; RECURRENT DISEASE; REINFECTION; RELAPSE; RISK; SURVIVAL;

AGE FACTORS; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHOLESTASIS, INTRAHEPATIC; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTERFERON-ALPHA; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; RECURRENCE; RIBAVIRIN; RISK FACTORS; TIME FACTORS;

HEPATITIS C VIRUS;

EID: 33845867392     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1118-5     Document Type: Article

References (0)